The protein science of biosimilars-Reference-Cited by-同舟云学术

The protein science of biosimilars

Published:2006-10-01 Issue:suppl_5 Volume:21 Page:v4-v8
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Kuhlmann Martin,Covic Adrian

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/21/suppl_5/v4/6835674/gfl474.pdf

Reference17 articles.

1. Buehler GJ and Conner D. The FDA Process for Approving Generic Drugs. FDA Office of Generic Drugs http://www.connectlive.com/events/genericdrugs/2006.

2. Baenziger JU, Kumar S, Brodbeck RM, Smith PL, Beranek MC. (1992) Circulatory half-life but not interaction with the lutropin/chorionic gonadotropin receptor is modulated by sulfation of bovine lutropin oligosaccharides. Proc Natl Acad Sci USA89:334–338.

3. Misaizu T, Matsuki S, Strickland TW, et al. (1995) Role of antennary structure of N-linked sugar chains in renal handling of recombinant human erythropoietin. Blood86:4097–4104.

4. Shinkawa T, Nakamura K, Yamane N, et al. (2003) The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem278:3466–3473.

5. Storring PL, Tiplady RJ, Gaines Das RE, Rafferty B, Mistry YG. (1996) Lectin-binding assays for the isoforms of human erythropoietin: comparison of urinary and four recombinant erythropoietins. J Endocrinol150:401–412.

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of adalimumab biosimilar in patients with inflammatory bowel disease;Farmacia Hospitalaria;2024-04

2. Bioavailability and bioequivalence;Physico-Chemical Aspects of Dosage Forms and Biopharmaceutics;2024

3. Transforming Drug Design: Innovations in Computer-Aided Discovery for Biosimilar Agents;BioMedInformatics;2023-12-08

4. Production of recombinant scorpion antivenoms in E. coli: current state and perspectives;Applied Microbiology and Biotechnology;2023-05-18